B06.02 Rubella meningitis

Name of the Condition

• Rubella meningitis

Summary

Rubella meningitis is a rare neurological complication of rubella infection, characterized by inflammation of the meninges (the protective membranes covering the brain and spinal cord). It occurs when the rubella virus invades the central nervous system, leading to acute neurological symptoms. This condition may develop during or after the acute phase of rubella, which typically presents with a rash and fever. Meningitis is more common in individuals with congenital rubella or immunocompromised states, though it can occur in otherwise healthy people.

Causes

Rubella meningitis is caused by the rubella virus, a togavirus transmitted via respiratory droplets. The virus may cross the blood-brain barrier, directly infecting neural tissues, or trigger an immune-mediated inflammatory response. This neurological involvement is a rare complication of primary rubella infection or reactivation in susceptible individuals.

Risk Factors

• Lack of prior rubella immunity or vaccination.
• Congenital rubella syndrome, where the virus is transmitted in utero.
• Immunocompromised conditions (e.g., HIV, chemotherapy) increasing susceptibility to severe disease.
• Advanced age or preexisting neurological disorders.

Symptoms

• Acute onset of fever, headache, and altered mental status.
• Stiff neck, photophobia, or nausea/vomiting.
• Focal neurological deficits (e.g., weakness, sensory changes) or seizures.
• Confusion, disorientation, or lethargy.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, followed by laboratory testing. Cerebrospinal fluid (CSF) analysis may show elevated white blood cells, increased protein, and normal or low glucose levels. Polymerase chain reaction (PCR) testing of CSF or serum can detect rubella virus. Imaging (e.g., MRI or CT) may rule out other causes of meningitis. Serological tests for rubella antibodies may confirm recent infection.

Treatment Options

Treatment focuses on supportive care, including pain management, hydration, and monitoring for complications. Antiviral therapy is not typically used, as rubella is a viral infection. In severe cases, corticosteroids may reduce inflammation. Vaccination against rubella is recommended for prevention in susceptible individuals.

Prognosis and Follow-Up

Prognosis depends on the severity of infection and underlying health status. Most patients recover fully with appropriate care, but some may experience residual neurological symptoms. Follow-up includes monitoring for complications and ensuring complete recovery. Immunocompromised patients may require extended observation.

Complications

• Persistent neurological deficits (e.g., cognitive impairment, motor weakness).
• Seizure disorders or chronic headaches.
• Increased risk of other infections due to weakened immunity.
• Rarely, progression to encephalitis or other severe neurological conditions.

Lifestyle & Prevention

• Ensure up-to-date rubella vaccination, especially for children and women of childbearing age.
• Avoid close contact with infected individuals during outbreaks.
• Practice good hygiene (e.g., handwashing) to reduce transmission risk.
• Maintain a healthy immune system through balanced nutrition and regular medical care.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden severe headache, fever, stiff neck, confusion, or neurological symptoms (e.g., weakness, seizures) after rubella exposure or infection. Early diagnosis and treatment improve outcomes.

Tips for Medical Coders

Use B06.02 for cases of rubella meningitis confirmed by clinical and laboratory findings. Document the presence of meningeal inflammation (e.g., CSF analysis results) and rubella infection to support coding. Differentiate from other causes of meningitis (e.g., bacterial) to ensure accurate code assignment.